← Back
$APUS All transactions

Apimeds Pharmaceuticals US, Inc.

A

$ Value

$0

Shares

3,000

Price

$0

Filed

Oct 17

Insider

Name

Kim Christopher

Title

Chairman and CMO

CIK

0002040022

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-15

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,000

Footnotes

The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's service to the issuer continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the issuer's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full upon the occurrence of a Change in Control, as defined in the Plan.

Filing Info

Accession No.

0002040022-25-000002

Form Type

4

Issuer CIK

0001894525

Kim Christopher's History

Date Ticker Type Value
2025-10-15 APUS A $0
2025-05-16 APUS A $0
2025-05-14 APUS $14K
2025-05-13 APUS $36K

Other Insiders at APUS (90d)

No other insider activity at this issuer in the last 90 days.